Developing a vaccine for COVID-19 within one year is a herculean task. Getting the vaccine to the hundreds of millions if not billions of people who need it—especially in poorer countries—may be even harder.
Governments and the private sector are working together in Asia and the Pacific to chart a path toward re-opening businesses during the midst of the pandemic.
African swine fever has cost Asia between $55 billion and $130 billion, including as much as $77 billion in lost revenue.
Governments and private companies are working together to find innovative digital solutions to the problems presented by the COVID-19 crisis.
Rebooting the economy: What countries need to know about COVID-19 testing as they relax restrictions
Experts agree that safely restarting economies hinges on widespread COVID-19 testing. But what does that mean across countries with varying testing capacities?
Эксперты сходятся во мнении, что безопасное восстановление экономики зависит от внедрения обширного тестирования на COVID-19. Но что это означает в разных странах с разным потенциалом тестирования?
As the pandemic continues, the supply chains producing vital personal protective equipment are starting to fail, causing shortages. Countries and international organizations can fill these gaps by working together.
The Asia-Pacific region has the expertise and resources to take a leadership role in not only developing a COVID-19 vaccine but distributing it to those who need it most.
The COVID-19 pandemic could be an opportunity to take a more holistic approach to health and well-being, invest in health systems and in resilient supply chains.
კოვიდ-19-ის პანდემია შესაძლოა იყოს შანსი ჯანდაცვის გაძლიერებას და ჯანსაღი ცხოვრების დამკვიდრებას კომპლექსურად მივუდგეთ, განვახორციელოთ ინვესტიციები ჯანდაცვის სისტემებსა და უფრო მდგრადი მიწოდების ჯაჭვებში.